• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD FUSION OASIS ONE ACTION STENT INTRODUCTION SYSTEM; FGE CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD FUSION OASIS ONE ACTION STENT INTRODUCTION SYSTEM; FGE CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Catalog Number FS-OA-10
Device Problems Defective Device (2588); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/08/2021
Event Type  malfunction  
Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
As reported to customer relations: "e-mail forwarded from customer: 'the reason for my email is in regards to a situation that i wanted to make you aware of on friday (b)(6) with one of the cook- one action delivery stent introduction (g31527).Unfortunately the packaging was discarded but i was able to get the lot number.Lot number c1816503.While in the ercp procedure, the black introducer was fed onto the wire jag wire and into the patient.Once the dr got to the duodenum the introducer was visible on camera and the staff could visibly see a metal wire from the introducer.Normally this is just a plastic sheath.The dr then had to pull out the scope from the patient as well as the introducer because of the loose metal wire.This metal wire was not loose and visible prior to being inserted in the patient.Is there any way that we could get a credit for this product? please let me know if you have any questions.'" 1.Did any unintended section of the device remain inside the patient¿s body? no ¿ if yes, please describe.2.Was the patient hospitalized or was there prolonged hospitalization due to this occurrence? no ¿ if yes, please describe.3.Did the patient require any additional procedures due to this occurrence? no ¿ if yes, please describe.4.Did the product cause or contribute to the need for additional procedures? no ¿ if yes, please specify additional procedures and provide details.5.Has the complainant reported any adverse effects on the patient due to this occurrence? no 6.Has the complainant reported that the product caused or contributed to the adverse effects? no ¿ please specify adverse effects and provide details.Additional information provided by customer on 04nov2021: "hello, my name is (b)(6).I was one of the rns in the procedure.I have answered the questions to the best of my memory.Thanks ¿ does the complaint relate to: o device placement o device removal o observation prior to patient contact ¿ what was the target location for the stent? o common bile duct ¿ please describe the storage conditions of the device prior to use especially those pertaining to temperature and light exposure.O cool, dark room ¿ what is the reorder number, diameter and length of the wire guide that was used with this device in this procedure? o 0.035inch x 260cm wire ¿ was the wire guide lubricated prior to use? n/a, yes, no ¿ was the wire guide inspected for damage prior to use? n/a, yes, no ¿ was the device at the center of the complaint inspected for damage prior to use? n/a, yes, no ¿ were previous procedures i.E.Sphincterotomy etc.Carried out prior to placing the complaint device? n/a, yes-sphincterotomy, no o if yes, please indicate the procedure performed.¿ did the patient involved exhibit altered anatomy or tortuous anatomy? n/a, yes, no ¿ if not with the device in question, how was the procedure finished? an additional stent introducer was used ¿ were any other defects observed on the device prior to return (other than the reported complaint issue? yes, no o if yes, please detail any other defects observed.¿ what is the endoscope manufacturer, the model number and working channel size that was used for the procedure? not sure ¿ does the medical facility have a service/maintenance schedule associated with its endoscopes? n/a, yes, no ¿ please indicate the location in the body where the stent device was to be placed.I.E.Biliary duct, pancreatic duct, other.O if other, please specify.Common bile duct ¿ was resistance encountered when advancing the wire guide to the target location? n/a, yes, no ¿ was resistance encountered when advancing the introduction system in place to the target location? n/a, yes, no ¿ how did the physician deal with this resistance? attempt to push the introducer harder ¿ how did the physician determine the length of the stent to be used for the procedure? based on xray image ¿ where was the stricture located in the duct? too long ago to recall ¿ was the stricture dilated prior to placing the device? no o if so, please indicate what device(s) were used.¿ was resistance encountered when advancing the stent through the obstructed area? n/a, yes, no ¿ after placement, was stent position verified? n/a, yes, no o if yes, please describe how.Visual evidence of bile flow and x-ray image ¿ please estimate the amount of time the stent was in place prior to this occurrence.¿ please indicate whether the device broke in the endoscope or in the patient.N/a, endoscope, patient ¿ please indicate what tools were used during retrieval (e.G.Basket, balloon, snare, forceps etc.): the introducer was pulled out of the patient without tools ¿ were any modifications made to the complaint device or accessories used with the device in this procedure? (e.G.Guiding catheter shortened, stent cut etc.) n/a, yes, no o if yes, please indicate what modifications were made.¿ please indicate why the modifications were necessary.¿ please indicate any other endoscopic accessories (if any) that came into contact with the stent or introduction system during the procedure.¿ were any other defects (other than the complaint issue) observed on the device prior to return (e.G.Kink)? n/a, yes, no o if yes, please specify what was observed and where on the device it was observed."--did (b)(6) 2021.2.1 for all complaints, ask: 2.1.1 does the complaint relate to: ¿ device placement ¿ device removal ¿ observation prior to patient contact 2.1.2 what was the target location for the stent? 2.1.3 please describe the storage conditions of the device prior to use especially those pertaining to temperature and light exposure.2.1.4 *what is the reorder number, diameter and length of the wire guide that was used with this device in this procedure?* 2.1.5 was the wire guide lubricated prior to use? n/a, yes, no 2.1.6 *was the wire guide inspected for damage prior to use? n/a, yes, no* 2.1.7 was the device at the center of the complaint inspected for damage prior to use? n/a, yes, no 2.1.8 were previous procedures i.E.Sphincterotomy etc.Carried out prior to placing the complaint device? n/a, yes, no ¿ if yes, please indicate the procedure performed.2.1.9 did the patient involved exhibit altered anatomy or tortuous anatomy? n/a, yes, no 2.1.10 * if not with the device in question, how was the procedure finished?* 2.1.13 were any other defects observed on the device prior to return (other than the reported complaint issue? yes, no ¿ if yes, please detail any other defects observed.2.2 for complaints occurring during use (once in contact with endoscope) also ask: 2.2.1 had a sphincterotomy been performed prior to this occurrence? n/a, yes, no 2.2.2 what is the endoscope manufacturer, the model number and working channel size that was used for the procedure? 2.2.3 does your medical facility have a service/maintenance schedule associated with its endoscopes? n/a, yes, no 2.2.4 please indicate the location in the body where the stent device was to be placed.I.E.Biliary duct, pancreatic duct, other.¿ if other, please specify.2.2.5 *was resistance encountered when advancing the wire guide to the target location? n/a, yes, no * 2.2.6 *was resistance encountered when advancing the introduction system in place to the target location? n/a, yes, no * ¿ how did the physician deal with this resistance? 2.2.7 how did the physician determine the length of the stent to be used for the procedure? 2.2.8 where was the stricture located in the duct? 2.2.9 *was the stricture dilated prior to placing the device?* ¿ if so, please indicate what device(s) were used.2.2.10 *was resistance encountered when advancing the stent through the obstructed area? n/a, yes, no * 2.2.11 after placement, was stent position verified? n/a, yes, no ¿ if yes, please describe how.2.2.12 please estimate the amount of time the stent was in place prior to this occurrence.2.2.14 please indicate whether the device broke in the endoscope or in the patient.N/a, endoscope, patient ¿ if yes, please indicate what tools were used during retrieval (e.G.Basket, balloon, snare, forceps etc.): 2.2.16 were any modifications made to the complaint device or accessories used with the device in this procedure? (e.G.Guiding catheter shortened, stent cut etc.) n/a, yes, no ¿ if yes, please indicate what modifications were made: 2.2.17 please indicate why the modifications were necessary.2.2.18 please indicate any other endoscopic accessories (if any) that came into contact with the stent or introduction system during the procedure.2.2.22 were any other defects (other than the complaint issue) observed on the device prior to return (e.G.Kink)? n/a, yes, no ¿ if yes, please specify what was observed and where on the device it was observed.
 
Manufacturer Narrative
Supplemental report (cancellation report) is being submitted due to the completion of the investigation.No adverse effect to the patient was reported as occurring.The event does not meet the criteria of an fda ¿serious injury¿ report or ¿malfunction¿ report as per fda guidelines ¿medical device reporting for manufacturers (2016)¿.Failure mode assigned on completion of the investigation has an overall risk of low (iia).Device evaluation: the fs-oa-10 device of lot number c1816503 involved in this complaint was not available for evaluation.With the information provided, a document-based investigation was conducted.Document review: prior to distribution fs-oa-10 devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for fs-oa-10 of lot number c1816503 did not reveal any discrepancies that could have contributed to this complaint issue.The review of relevant manufacturing records confirms the failure mode has not previously occurred with the current lot number.Based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with lot number c1816503.It should be noted that the instructions for use (ifu0096-1) states the following: ¿visually inspect with particular attention to kinks, bends and breaks.If an abnormality is detected that would prohibit proper working condition, do not use¿.There is no evidence to suggest the user did not follow the ifu.Root cause review: a definitive root cause could not be determined from the available information.A possible root cause could be attributed to excessive pressure applied while attempting to push the introducer harder.Summary: the complaint is confirmed based on customer testimony.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental report (cancellation report) is being submitted due to the completion of the investigation.No adverse effect to the patient was reported as occurring.The event does not meet the criteria of an fda ¿serious injury¿ report or ¿malfunction¿ report as per fda guidelines ¿medical device reporting for manufacturers (2016)¿.Failure mode assigned on completion of the investigation has an overall risk of low (iia).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FUSION OASIS ONE ACTION STENT INTRODUCTION SYSTEM
Type of Device
FGE CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
aisling hassett
o halloran road
national technology park
limerick 
061334440
MDR Report Key12786919
MDR Text Key286874433
Report Number3001845648-2021-00798
Device Sequence Number1
Product Code FGE
UDI-Device Identifier10827002315270
UDI-Public(01)10827002315270(17)240401(10)C1816503
Combination Product (y/n)N
PMA/PMN Number
K851962
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/01/2024
Device Catalogue NumberFS-OA-10
Device Lot NumberC1816503
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/08/2021
Event Location Hospital
Initial Date Manufacturer Received 10/12/2021
Initial Date FDA Received11/10/2021
Supplement Dates Manufacturer Received10/12/2021
Supplement Dates FDA Received04/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number1
Patient Sequence Number1
-
-